CBP-307
CBP-307AU002
Phase 1 small_molecule completed
Quick answer
CBP-307 for Autoimmune Diseases is a Phase 1 program (small_molecule) at Connect Biopharma Holdings Ltd with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Connect Biopharma Holdings Ltd
- Indication
- Autoimmune Diseases
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed